Sweiss, N.J. et al. 2014. Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 31, 1 (Apr. 2014), 46–54.